Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehmet Sen

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
The Journal of Molecular Diagnostics : JMD|January 14, 2012
Next-generation sequencing for simultaneous determination of human papillomavirus load, subtype, and associated genomic copy number changes in tumorsCaroline Conway, Rebecca Chalkley, Alec High, et al.
BMC Cancer|November 5, 2015
Multimodality imaging with CT, MR and FDG-PET for radiotherapy target volume delineation in oropharyngeal squamous cell carcinomaDavid Bird, Andrew F Scarsbrook, Jonathan Sykes, et al.
Nature Communications|December 1, 2018
Cis interaction between sialylated FcγRIIA and the αI-domain of Mac-1 limits antibody-mediated neutrophil recruitmentGurpanna Saggu, Koshu Okubo, Yunfeng Chen, et al.
International Journal of Radiation Oncology, Biology, Physics|September 20, 2005
Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modulesMustafa Cengiz, Enis Ozyar, Mustafa Esassolak, et al.
International Journal of Radiation Oncology, Biology, Physics|December 10, 2023
Randomized Phase 3 Trial of the Hypoxia Modifier Nimorazole Added to Radiation Therapy With Benefit Assessed in Hypoxic Head and Neck Cancers Determined Using a Gene Signature (NIMRAD)David J Thomson, Nick J Slevin, Helen Baines, et al.
Head & Neck|August 22, 2012
Quality of life in patients with head and neck cancer receiving targeted or multimodal therapy--update of the EORTC QLQ-H&N35, Phase ISusanne Singer, Juan I Arraras, Ingo Baumann, et al.
Angewandte Chemie (International Ed. in English)|March 8, 2021
Neutralizing Aptamers Block S/RBD-ACE2 Interactions and Prevent Host Cell InfectionXiaohui Liu, Yi-Ling Wang, Jacky Wu, et al.
Trials|January 14, 2024
CompARE: study protocol for a phase III randomised controlled platform trial comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancerHisham Mehanna, Piers Gaunt, Anthony Kong, et al.
Angewandte Chemie (Weinheim an Der Bergstrasse, Germany)|July 7, 2021
Neutralizing Aptamers Block S/RBD-ACE2 Interactions and Prevent Host Cell InfectionXiaohui Liu, Yi-Ling Wang, Jacky Wu, et al.
Clinical and Translational Radiation Oncology|July 6, 2021
A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemicIfigenia Vasiliadou, David Noble, Andrew Hartley, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
The Journal of Molecular Diagnostics : JMD|January 14, 2012
Next-generation sequencing for simultaneous determination of human papillomavirus load, subtype, and associated genomic copy number changes in tumorsCaroline Conway, Rebecca Chalkley, Alec High, et al.
BMC Cancer|November 5, 2015
Multimodality imaging with CT, MR and FDG-PET for radiotherapy target volume delineation in oropharyngeal squamous cell carcinomaDavid Bird, Andrew F Scarsbrook, Jonathan Sykes, et al.
Nature Communications|December 1, 2018
Cis interaction between sialylated FcγRIIA and the αI-domain of Mac-1 limits antibody-mediated neutrophil recruitmentGurpanna Saggu, Koshu Okubo, Yunfeng Chen, et al.
International Journal of Radiation Oncology, Biology, Physics|September 20, 2005
Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modulesMustafa Cengiz, Enis Ozyar, Mustafa Esassolak, et al.
International Journal of Radiation Oncology, Biology, Physics|December 10, 2023
Randomized Phase 3 Trial of the Hypoxia Modifier Nimorazole Added to Radiation Therapy With Benefit Assessed in Hypoxic Head and Neck Cancers Determined Using a Gene Signature (NIMRAD)David J Thomson, Nick J Slevin, Helen Baines, et al.
Head & Neck|August 22, 2012
Quality of life in patients with head and neck cancer receiving targeted or multimodal therapy--update of the EORTC QLQ-H&N35, Phase ISusanne Singer, Juan I Arraras, Ingo Baumann, et al.
Angewandte Chemie (International Ed. in English)|March 8, 2021
Neutralizing Aptamers Block S/RBD-ACE2 Interactions and Prevent Host Cell InfectionXiaohui Liu, Yi-Ling Wang, Jacky Wu, et al.
Trials|January 14, 2024
CompARE: study protocol for a phase III randomised controlled platform trial comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancerHisham Mehanna, Piers Gaunt, Anthony Kong, et al.
Angewandte Chemie (Weinheim an Der Bergstrasse, Germany)|July 7, 2021
Neutralizing Aptamers Block S/RBD-ACE2 Interactions and Prevent Host Cell InfectionXiaohui Liu, Yi-Ling Wang, Jacky Wu, et al.
Clinical and Translational Radiation Oncology|July 6, 2021
A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemicIfigenia Vasiliadou, David Noble, Andrew Hartley, et al.
Pageof 7